Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew(Lung Institute), Peter Openshaw(Imperial College London), Jasmin Sidhu(Imperial College London), Dan Wootton(University of Liverpool), Christopher Davis(MRC University of Glasgow Centre for Virus Research), J Nunag(Imperial College Healthcare NHS Trust), Alex Horsley(University of Manchester), Annemarie B Docherty(Edinburgh Royal Infirmary), Matthew K. Siggins(Lung Institute), Betty Raman(John Radcliffe Hospital), Claudia Efstathiou(Trinity College Dublin), J. Kenneth Baillie(Roslin Institute), Sarah Rowland‐Jones(John Radcliffe Hospital), Shubha Talwar(Imperial College London), Dawid Swieboda(Imperial College London), Jennifer K Quint(Roland Hill (United Kingdom)), Christopher E. Brightling(University of Leicester), Michael Marks(American Heart Association), Nicola Logan(MRC University of Glasgow Centre for Virus Research), Sara Fontanella(Imperial College London), Malcolm G. Semple(University of Liverpool), Antonia Ho(University of Liverpool), Thushan I. de Silva(Sheffield Teaching Hospitals NHS Foundation Trust), James D. Chalmers(University of Dundee), Ryan S. Thwaites(Lung Institute), Louise V. Wain(University of Leicester), Sam Scott(MRC University of Glasgow Centre for Virus Research), Brian J. Willett(MRC University of Glasgow Centre for Virus Research), Rachael A Evans(University of Leicester), Ewen M. Harrison(Centre for Inflammation Research), Ling‐Pei Ho(University of Oxford), Susanna Dunachie(University of Oxford), A. A. Roger Thompson(University of Sheffield), Shona C. Moore(University of Liverpool), Lance Turtle(University of Liverpool), Andy Cross(University of Liverpool), Noura Mohamed(Imperial College Healthcare NHS Trust), Clara King(Imperial College Healthcare NHS Trust), Luke Howard(Imperial College London), Krisnah Poinasamy(Asthma UK), Onn Min Kon(Imperial College London)
Cited by 18
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
|Stroke|2006|1.9k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k